App-technology to Improve Healthy Lifestyle Behaviors Among Working Adults

August 13, 2019 updated by: Ylva Trolle Lagerros, Karolinska Institutet

Using App-technology and a Personalized Health Plan to Improve Lifestyle Habits Among Working Adults - a Randomized Controlled Trial

The aim of this study is to evaluate if modern technology such as smartphone applications can be used to facilitate lifestyle changes and thereby improve health-related quality of life in gainfully employed persons in the general population in Stockholm, Sweden. The hypothesis is that at follow-up, the intervention group that use the new application will have improved health-related quality of life and other lifestyle habits including diet, physical activity and sleep, as well as biomarkers, compared to a control group.

Study Overview

Study Type

Interventional

Enrollment (Actual)

209

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Select One...
      • Stockholm, Select One..., Sweden, 17176
        • Karolinska Institutet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years of age or older
  • Ability to communicate in Swedish
  • Have access to and use a smartphone

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: App technology and coaching
Participants in the intervention group with app technology and coaching participate in a first meeting with the coach and will thereafter receive active support from the coach every 4 weeks for the duration of the intervention.
Access to the smartphone-app during 12 weeks. A personal health goal related to for example diet, physical activity or stress habits, is set together with a heath coach. Participants receive continuous coaching every 4 weeks during follow-up.
Experimental: App technology only
Participants in the intervention group with only app technology participate in a first meeting with the coach but do not get any additional support during follow-up.
Access to the smartphone-app during 12 weeks. A personal health goal related to for example diet, physical activity or stress habits, is set together with a heath coach. Participants receive continuous coaching every 4 weeks during follow-up.
No Intervention: Control group
Participants in the control group participate in baseline assessments. The control group will get access to the app and will have a meeting with a coach after 12 weeks of follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health related quality of life assessed by the RAND-36 questionnaire
Time Frame: 12-weeks follow-up
Mental and Physical Health Scores (range 0-100) are assessed using 36 questions
12-weeks follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity
Time Frame: Baseline (week 0) and at 12-weeks follow-up
Minutes per day spent on a sedentary, light, moderate or higher activity level assessed using accelerometers
Baseline (week 0) and at 12-weeks follow-up
HbA1c (Heamoglobin A1c)
Time Frame: Baseline (week 0) and at 12-weeks follow-up
mmol/mol
Baseline (week 0) and at 12-weeks follow-up
Total cholesterol
Time Frame: Baseline (week 0) and at 12-weeks follow-up
(mmol/L)
Baseline (week 0) and at 12-weeks follow-up
Apolipoprotein A1
Time Frame: Baseline (week 0) and at 12-weeks follow-up
(g/l)
Baseline (week 0) and at 12-weeks follow-up
Apolipoprotein B
Time Frame: Baseline (week 0) and at 12-weeks follow-up
(g/l)
Baseline (week 0) and at 12-weeks follow-up
Body Mass Index
Time Frame: Baseline (week 0) and at 12-weeks follow-up
(kg/m2)
Baseline (week 0) and at 12-weeks follow-up
Body weight
Time Frame: Baseline (week 0) and at 12-weeks follow-up
(kg)
Baseline (week 0) and at 12-weeks follow-up
Waist circumference
Time Frame: Baseline (week 0) and at 12-weeks follow-up
(cm)
Baseline (week 0) and at 12-weeks follow-up
Body composition
Time Frame: Baseline (week 0) and at 12-weeks follow-up
(%Body Fat)
Baseline (week 0) and at 12-weeks follow-up
Blood pressure (Systolic and Diastolic)
Time Frame: Baseline (week 0) and at 12-weeks follow-up
(mmHg)
Baseline (week 0) and at 12-weeks follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in dietary habits
Time Frame: Baseline (week 0) and at 12-weeks follow-up
Intake of macro- and Micro nutrients are assessed based on responses to a food frequency questionnaire
Baseline (week 0) and at 12-weeks follow-up
Change in eating behaviors according to the Three Factor Eating Questionnaire (TFEQ)
Time Frame: Baseline (week 0) and at 12-weeks follow-up
Emotional eating, uncontrolled eating, and cognitive restricted eating are assessed using a 21-item questionnaire
Baseline (week 0) and at 12-weeks follow-up
Change in tobacco use (user/non-user)
Time Frame: Baseline (week 0) and at 12-weeks follow-up
Smoking and Swedish snuff use
Baseline (week 0) and at 12-weeks follow-up
Change in sleeping habits
Time Frame: Baseline (week 0) and at 12-weeks follow-up
Assessed using a modified 13-item Karolinska Sleep questionnaire
Baseline (week 0) and at 12-weeks follow-up
Change in perceived Purpose In Life (PIL)
Time Frame: Baseline (week 0) and at 12-weeks follow-up
6-item questionnaire
Baseline (week 0) and at 12-weeks follow-up
Change in perceived stress levels
Time Frame: Baseline (week 0) and at 12-weeks follow-up
Assessed using the 14-item perceived stress scale (PSS)
Baseline (week 0) and at 12-weeks follow-up
Change in motivation to make lifestyle changes
Time Frame: Baseline (week 0) and at 12-weeks follow-up
Assessed using Prochaskas' transtheoretical model of behavior change
Baseline (week 0) and at 12-weeks follow-up
Social support for an overall healthy lifestyle
Time Frame: Baseline (week 0)
Social support for maintenance of a healthy Lifestyle from family, friends and co-workers is assessed by a 5-item questionnaire
Baseline (week 0)
Change in self-reported sitting time and physical activity
Time Frame: Baseline (week 0) and at 12-weeks follow-up
Assessed by 6 questions on sitting time and exercise
Baseline (week 0) and at 12-weeks follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 16, 2018

Primary Completion (Actual)

May 15, 2019

Study Completion (Actual)

May 15, 2019

Study Registration Dates

First Submitted

May 8, 2018

First Submitted That Met QC Criteria

June 25, 2018

First Posted (Actual)

July 6, 2018

Study Record Updates

Last Update Posted (Actual)

August 14, 2019

Last Update Submitted That Met QC Criteria

August 13, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 2018/411-31

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on App-technology and active coaching to improve lifestyles behaviors

3
Subscribe